Bestrahlungstechniken beim Mammakarzinom

In den beiden letzten Jahrzehnten hat sich die Strahlentherapie beim Mammakarzinom deutlich weiterentwickelt. Am Bestrahlungsgerät erlauben moderne Bildgebungsverfahren eine täglich reproduzierbare und präzise Lagerung. Das Ausmaß des Bestrahlungsvolumens orientiert sich zunehmend am individuellen Risiko. Dies führt häufig zu kürzeren Bestrahlungsserien und zu einer verringerten Strahlenbelastung an der behandelten Brust und an den angrenzenden Organen.

Schlüsselwörter

Mammakarzinom - Strahlentherapie - Positionierung - Fraktionierung - Hyperthermie

• Literatur

• 1 [Anonym]. Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): S3-Leitlinie Früherkennung, Diagnose, Therapie und Nachsorge des Mammakarzinoms, Version 4.4, AWMF Registernummer: 032–045OL. 2021 Accessed August 26, 2022 at: http://www.leitlinienprogramm-onkologie.de/leitlinien/mammakarzinom/
• 2 Wang SL, Fang H, Song YW. et al. Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial. Lancet Oncol 2019; 20: 352-360
• 3 Clarke M, Collins R, Darby S. et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 366: 2087-2106
• 4 Darby S, McGale P, Correa C. Early Breast Cancer Trialists’ Collaborative Group, (EBCTCG). et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 2011; 378: 1707-1716
• 5 Group ST, Bentzen SM, Agrawal RK. et al. The UK Standardisation of Breast Radiotherapy (START) trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 2008; 371: 1098-1107
• 6 Krug D, Baumann R, Combs SE. et al. Moderate hypofractionation remains the standard of care for whole-breast radiotherapy in breast cancer: considerations regarding FAST and FAST-Forward. Strahlenther Onkol 2021; 197: 269-280
• 7 Budach W, Bolke E, Kammers K. et al. Adjuvant radiation therapy of regional lymph nodes in breast cancer – a meta-analysis of randomized trials- an update. Radiat Oncol 2015; 10: 258
• 8 Strnad V, Krug D, Sedlmayer F. et al. DEGRO practical guideline for partial-breast irradiation. Strahlenther Onkol 2020; 196: 749-763
• 9 Ott OJ, Strnad V, Hildebrandt G. et al. GEC-ESTRO multicenter phase 3-trial: accelerated partial breast irradiation with interstitial multicatheter brachytherapy versus external beam whole breast irradiation: early toxicity and patient compliance. Radiother Oncol 2016; 120: 119-123
• 10 Ott OJ, Strnad V, Stillkrieg W. et al. Accelerated partial breast irradiation with external beam radiotherapy: first results of the German phase 2 trial. Strahlenther Onkol 2017; 193: 55-61
• 11 Strnad V, Ott OJ, Hildebrandt G. et al. 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial. Lancet 2016; 387: 229-238
• 12 Laplana M, Cozzi S, Najjari D. et al. Five-year results of accelerated partial breast irradiation: a single-institution retrospective review of 289 cases. Brachytherapy 2021; 20: 807-817
• 13 Hannoun-Levi JM, Gal J, Van Limbergen E. et al. Salvage mastectomy versus second conservative treatment for second ipsilateral breast tumor event: a propensity score-matched cohort analysis of the GEC-ESTRO breast cancer working group database. Int J Radiat Oncol Biol Phys 2021; 110: 452-461
• 14 Renner H, van Kampen M. Simultane Radiochemotherapie beim lokoregional rezidivierenden Mammakarzinom nach Mastektomie. Ergebnisse bei Patienten mit makroskopischem Residualtumor R2. Strahlenther Onkol 1994; 170: 441-452
• 15 Jones EL, Oleson JR, Prosnitz LR. et al. Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol 2005; 23: 3079-3085
• 16 Vernon CC, Hand JW, Field SB. et al. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group. Int J Radiat Oncol Biol Phys 1996; 35: 731-744
• 17 Auoragh A, Strnad V, Ott OJ. et al. Re-irradiation of the chest wall for local breast cancer recurrence: results of salvage brachytherapy with hyperthermia. Strahlenther Onkol 2016; 192: 617-623
• 18 Haussmann J, Tamaskovics B, Bolke E. et al. Addition of chemotherapy to hyperfractionated radiotherapy in advanced head and neck cancer-a meta-analysis. Strahlenther Onkol 2019; 195: 1041-1049
• 19 Dobsicek Trefna H, Crezee J, Schmidt M. et al. Quality assurance guidelines for superficial hyperthermia clinical trials: II. Technical requirements for heating devices. Strahlenther Onkol 2017; 193: 351-366
• 20 Trefna HD, Crezee H, Schmidt M. et al. Quality assurance guidelines for superficial hyperthermia clinical trials: I. Clinical requirements. Int J Hyperthermia 2017; 33: 471-482